Your browser doesn't support javascript.
loading
In inflammatory myopathies, dropped head/bent spine syndrome is associated with scleromyositis: an international case-control study.
Pijnenburg, Luc; Giannini, Margherita; Bouchard-Marmen, Maude; Arnaud, Laurent; Barsotti, Simone; Bellando-Randone, Silvia; Bernardi, Livio; Bini, Paola; Blagojevic, Jelena; Codullo, Veronica; Couderc, Marion; De Moreuil, Claire; Dernis, Emanuelle; Diamanti, Luca; Dubost, Jean Jacques; Duval, Fanny; Emmi, Giacomo; Galempoix, Jean-Marc; Geny, Bernard; Gottenberg, Jacques-Eric; Groza, Monica; Guffroy, Aurelien; Guichard, Isabelle; Guilpain, Philippe; Hervier, Baptiste; Hudson, Marie; Iaccarino, Luca; Iannone, Florenzo; Lebrun, Delphine; Marchioni, Enrico; Mariampillai, Kuberaka; Maurier, Francois; Mosca, Marta; Nadaj-Pakleza, Aleksandra; Nannini, Carlotta; Piot, Jean-Maxime; Prieto-González, Sergio; Poursac, Nicolas; Rouanet, Eglantine; Sellam, Jérémie; Selva-O'Callaghan, Albert; Séverac, François; Sibilia, Jean; Sole, Guilhem; Soulages, Antoine; Terrier, Benjamin; Tournadre, Anne; Troyanov, Yves; Vernier, Nathalie; Vesperini, Veronique.
Afiliação
  • Pijnenburg L; Service de rhumatologie, Centre de Référence des Maladies Auto-immunes Systémiques Rares Est Sud-Ouest Hôpitaux Universitaires de Strasbourg, Université de Strasbourg, Strasbourg, France.
  • Giannini M; Service de rhumatologie, Centre de Référence des Maladies Auto-immunes Systémiques Rares Est Sud-Ouest Hôpitaux Universitaires de Strasbourg, Université de Strasbourg, Strasbourg, France.
  • Bouchard-Marmen M; Exploration fonctionnelle musculaire, Service de Physiologie Explorations Fonctionnelles Musculaires, Hôpitaux Universitaires de Strasbourg, Université de Strasbourg, Strasbourg, France.
  • Arnaud L; Division of Rheumatology, CHU de Quebec-Universite Laval, Quebec, Quebec, Canada.
  • Barsotti S; Service de rhumatologie, Centre de Référence des Maladies Auto-immunes Systémiques Rares Est Sud-Ouest Hôpitaux Universitaires de Strasbourg, Université de Strasbourg, Strasbourg, France.
  • Bellando-Randone S; Department of Rheumatology and Clinical Immunology Unit, University of Pisa, Pisa, Italy.
  • Bernardi L; Department of Experimental and Clinical Medicine, Universitaria Careggi, Azienda Ospedaliera, Florence, Italy.
  • Bini P; Departement of rheumatology, University of Padova, Padova, Italy.
  • Blagojevic J; Department of neurology, Neurological Institute Mondino, University of Pavia, Pavia, Italy.
  • Codullo V; Department of Experimental and Clinical Medicine, Universitaria Careggi, Azienda Ospedaliera, Florence, Italy.
  • Couderc M; Rheumatology Division, University and IRCCS Policlinico S. Matteo Foundation Pavia, Pavia, Italy.
  • De Moreuil C; Service de rhumatologie, Hôpitaux Universitaires de Clermont-Ferrand, Clermont-Ferrand, France.
  • Dernis E; Service de médecine interne, Hôpitaux Universitaires de Brest, Brest, France.
  • Diamanti L; Service de rhumatologie, Centre hospitalier Le Mans, Le Mans, France.
  • Dubost JJ; Department of neurology, Neurological Institute Mondino, University of Pavia, Pavia, Italy.
  • Duval F; Service de médecine interne, Hôpitaux Universitaires de Clermont-Ferrand, Clermont-Ferrand, France.
  • Emmi G; Service de neurologie, Hôpitaux Universitaires de Bordeaux, Bordeaux, France.
  • Galempoix JM; Department of Experimental and Clinical Medicine, Universitaria Careggi, Azienda Ospedaliera, Florence, Italy.
  • Geny B; Service de Médecine Interne, Centre Hospitalier de Charleville-Mézières, Charleville-Mézières, France.
  • Gottenberg JE; Exploration fonctionnelle musculaire, Service de Physiologie Explorations Fonctionnelles Musculaires, Hôpitaux Universitaires de Strasbourg, Université de Strasbourg, Strasbourg, France.
  • Groza M; Service de rhumatologie, Centre de Référence des Maladies Auto-immunes Systémiques Rares Est Sud-Ouest Hôpitaux Universitaires de Strasbourg, Université de Strasbourg, Strasbourg, France.
  • Guffroy A; Service de médecine interne, Centre hospitalier Colmar, Colmar, France.
  • Guichard I; Service d'immunologie clinique, Centre de Référence des Maladies Auto-immunes Systémiques Rares Est Sud-Ouest Hôpitaux Universitaires de Strasbourg, Université de Strasbourg, Strasbourg, France.
  • Guilpain P; Service de médecine interne, Hôpitaux Universitaires de Saint Etienne, Saint Etienne, France.
  • Hervier B; Service de médecine interne, Hôpitaux Universitaires de Montpellierr, Montpellier, France.
  • Hudson M; Service de médecine interne, Assistance publique - Hôpitaux de Paris, Saint Louis, Paris, France.
  • Iaccarino L; Department of medicine, Division of Rheumatology, Jewish General Hospital, McGill University, Montreal, Québec, Canada.
  • Iannone F; Departement of rheumatology, University of Padova, Padova, Italy.
  • Lebrun D; Department of rheumatology, University of Bari, Bari, Italy.
  • Marchioni E; Service de Médecine Interne, Centre Hospitalier de Charleville-Mézières, Charleville-Mézières, France.
  • Mariampillai K; Department of neurology, Neurological Institute Mondino, University of Pavia, Pavia, Italy.
  • Maurier F; Service de médecine interne, Assistance publique - Hôpitaux de Paris, Saint Louis, Paris, France.
  • Mosca M; Service de médecine interne, Hôpitaux privés de Metz, Metz, France.
  • Nadaj-Pakleza A; Department of Rheumatology and Clinical Immunology Unit, University of Pisa, Pisa, Italy.
  • Nannini C; Service de neurologie, Centre de référence des maladies neuromusculaires, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
  • Piot JM; Department of Rheumatology, Prato Hospital, Prato, Italy.
  • Prieto-González S; Service de rhumatologie, Centre hospitalier Le Mans, Le Mans, France.
  • Poursac N; Department of internal medicine, Hospital Clinic of Barcelona, Barcelona, Spain.
  • Rouanet E; Service de rhumatologie, Centre de Référence des Maladies Auto-immunes Systémiques Rares Est Sud-Ouest, Hôpitaux Universitaires de Bordeaux, Bordeaux, France.
  • Sellam J; Service de rhumatologie, Centre hospitalier Le Mans, Le Mans, France.
  • Selva-O'Callaghan A; Service de rhumatologie, Hôpital Saint Antoine, Assistance publique - Hôpitaux de Paris, Paris, France.
  • Séverac F; Department of internal medicine, Val d'Hebron General Hospital, Barcelona, Spain.
  • Sibilia J; Service de Santé Publique, GMRC; ICube, UMR 7357, Hôpitaux universitaires de Strasbourg, Université de Strasbourg, Strasbourg, France.
  • Sole G; Service de rhumatologie, Centre de Référence des Maladies Auto-immunes Systémiques Rares Est Sud-Ouest Hôpitaux Universitaires de Strasbourg, Université de Strasbourg, Strasbourg, France.
  • Soulages A; Service de neurologie, Hôpitaux Universitaires de Bordeaux, Bordeaux, France.
  • Terrier B; Service de neurologie, Hôpitaux Universitaires de Bordeaux, Bordeaux, France.
  • Tournadre A; Service de médecine interne, Hôpital Cochin Assistance publique - Hôpitaux de Paris Cochin, Paris, France.
  • Troyanov Y; Service de rhumatologie, Hôpitaux Universitaires de Clermont-Ferrand, Clermont-Ferrand, France.
  • Vernier N; Department of rheumatology, Hôpital Sacre Cœur Montréal, Université de Montréal, Montreal, Québec, Canada.
  • Vesperini V; Service de médecine interne, Hôpitaux Universitaires de Dijon, Dijon, France.
RMD Open ; 9(3)2023 09.
Article em En | MEDLINE | ID: mdl-37666644
BACKGROUND: Some myopathies can lead to dropped head or bent spine syndrome (DH/BS). The significance of this symptom has not been studied in inflammatory myopathies (IM). OBJECTIVES: To assess the significance of DH/BS in patients with IM. METHODS: Practitioners from five IM networks were invited to report patients with IM suffering from DH/BS (without other known cause than IM). IM patients without DH/BS, randomly selected in each participating centre, were included as controls at a ratio of 2 to 1. RESULTS: 49 DH/BS-IM patients (DH: 57.1%, BS: 42.9%) were compared with 98 control-IM patients. DH/BS-IM patients were older (65 years vs 53 years, p<0.0001) and the diagnosis of IM was delayed (6 months vs 3 months, p=0.009). Weakness prevailing in the upper limbs (42.9% vs 15.3%), dysphagia (57.1% vs 25.5%), muscle atrophy (65.3% vs 34.7%), weight loss (61.2% vs 23.5%) and loss of the ability to walk (24.5% vs 5.1%) were hallmarks of DH/BS-IM (p≤0.0005), for which the patients more frequently received intravenous immunoglobulins (65.3% vs 34.7%, p=0.0004). Moreover, DH/BS-IM patients frequently featured signs and/or complications of systemic sclerosis (SSc), fulfilling the American College of Rheumatology/European Alliance of Associations for Rheumatology criteria for this disease in 40.8% of the cases (vs 5.1%, p<0.0001). Distribution of the myopathy, its severity and its association with SSc were independently associated with DH/BS (p<0.05). Mortality was higher in the DH/BS-IM patients and loss of walking ability was independently associated with survival (p<0.05). CONCLUSION: In IM patients, DH/BS is a marker of severity and is associated with SSc (scleromyositis).
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Reumatologia / Escleroderma Sistêmico / Miosite Tipo de estudo: Diagnostic_studies / Observational_studies / Risk_factors_studies Limite: Aged / Humans / Middle aged Idioma: En Revista: RMD Open Ano de publicação: 2023 Tipo de documento: Article País de afiliação: França

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Reumatologia / Escleroderma Sistêmico / Miosite Tipo de estudo: Diagnostic_studies / Observational_studies / Risk_factors_studies Limite: Aged / Humans / Middle aged Idioma: En Revista: RMD Open Ano de publicação: 2023 Tipo de documento: Article País de afiliação: França